Rense.com

 
USDA's Veneman
Still Uncertain How
To Fix US Beef Trade

1-22-4
 
WASHINGTON (Reuters) - U.S. Agriculture Secretary Ann Veneman on Wednesday said she did not yet know what safety steps the United States would have to take on mad cow disease to convince Japan and other major importers of U.S. beef to reopen their markets.
 
Interviewed by North Dakota radio station WDAY, Veneman said, "I'm just not sure what it's going to take" to reopen those markets.
 
U.S. beef exports were virtually shut down after the Dec. 23 finding of one case of bovine spongiform encephalopathy in a dairy cow slaughtered in Washington state. The United States normally exports more than $3 billion worth of beef annually, about 10 percent of its production.
 
Veneman said "it's premature to project right now" when foreign countries' trade bans might be relaxed. But she noted that after Canada identified one case of the animal brain-wasting disease last spring, "It was about three months before we opened up any market to Canada...and that was very limited."
 
USDA officials are in Japan this week talking to counterparts about beef trade. Veneman said foreign countries should "at least open up to the least-risk product, boneless beef."
 
Veneman also said the Food and Drug Administration would make an announcement "very shortly" on possible new restrictions on the use of bovine material in animal feed.
 
"They (FDA) are in the process of reviewing all of those regulations now in light of the find of BSE in this country and they are expected to make some announcements with regard to further restrictions on feed very shortly," Veneman said.
 
U.S. meat industry sources have speculated the FDA might ban the use of bovine blood as a protein supplement for calves. Some consumer groups are calling for a much broader ban, one that would outlaw the use of any ruminant parts for all livestock feed, a move U.S. industry officials oppose.
 
Copyright © 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
 

Disclaimer





MainPage
http://www.rense.com


This Site Served by TheHostPros